Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 40.76
-0.20 (-0.49%)
At close: Apr 29, 2026
Hinova Pharmaceuticals Revenue
Hinova Pharmaceuticals had revenue of 26.03M CNY in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 46.50M, up 12,574.70% year-over-year. In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.47M with 5,480.12% growth.
Revenue (ttm)
46.50M
Revenue Growth
+12,574.70%
P/S Ratio
86.80
Revenue / Employee
267.21K
Employees
174
Market Cap
4.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boji Medical Technology | 949.94M |
| Shanghai Obio Technology (Group) Corp. | 267.70M |
| Baolingbao Biology | 2.81B |
| Pulike Biological Engineering | 1.10B |
| Guanhao Biotech | 387.75M |
| Qingdao Vland Biotech INC. | 1.37B |
| Hefei Lifeon Pharmaceutical | 1.55B |
| Shanghai Serum Bio-Technology | 197.68M |